Buy 2 get 1 free — everything calculated at checkout

Biosimilarity: The FDA Perspective

$32.00 Lowest price online — guaranteed

Price comparison

Publisher / Official store
$110.00
Our store
$32.00

Buy 2, get 1 free. Everything is calculated automatically at checkout.

Enter a valid email at checkout. Your ebook download link is sent to the email address you provide — double-check it before completing your order.

30-day money-back guarantee. File issue? We replace it or refund you — no questions asked.

IMPORTANT

Digital product — no physical item will be shipped

You'll receive a PDF download link by email immediately after checkout.

Can't find the ebook you're looking for?

Send us the book cover image via the live chat on our website and we'll request it for you. Estimated response time: 10 minutes.

Book details

Format
PDF — instant download
Language
English

About this book

⚠️📚THIS ISN'T A PHYSICAL BOOK!

Summary:The focus of this book is on how the U.S. FDA will approve biosimilar drugs, as learned from recent approvals by the FDA. Understanding the limitations of the statutory limits and non-inferiority testing are presented as tools to obviate patient trials and minimize testing of immunogenicity. An in-depth scientific, mathematical and statistical view of the tools required to establish biosimilarity of biological drugs of different complexity -- a must for every developer of biosimilars.Features: First comprehensive analysis based on new guidelines and approval packages of several biosimilarsPresents the first approach to challenge FDA in reducing or eliminating any testing in patients.Provides a comprehensive understanding of the U.S. statutory requirements vis-a-vis the regulatory guidelinesProvides model CQA and Analytical Similarity testing protocols for cytokines and monoclonal antibodiesAllow creation of a fast-to-market pathway to develop biosimilars

About the Author

Sarfaraz K. Niazi Ph.D, is Adjunct Professor at the faculty of University of Houston as well Chairman and President of Therapeutic Proteins Inc.

Author Sarfaraz K. Niazi
ISBN-13 9781315351377
Publisher CRC Press
Publication Date 10/03/2018
Page Count 436 pages

Why buy from us

  • 100% Authorised by publisher — licensed copy, never pirated
  • –84% Less than Amazon Kindle — lowest price guaranteed
  • Instant PDF delivered the moment your payment clears, 24/7
  • Full Complete edition — every chapter, no missing pages
Secure Checkout
Instant Download
24/7 Support

You may also like